kth.sePublications KTH
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Randomized Trials and Observational Studies: The Current Philosophical Controversy
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK, United Kingdom.
KTH, School of Architecture and the Built Environment (ABE), Philosophy and History, Philosophy. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK, United Kingdom.ORCID iD: 0000-0003-2173-4954
2025 (English)In: Handbook of the Philosophy of Medicine / [ed] Thomas Schramme; Mary Jean Walker, Springer Nature , 2025, p. 1125-1138Chapter in book (Other academic)
Abstract [en]

The supposed superiority of randomized over non-randomized studies is used to justify claims about therapeutic effectiveness of medical interventions and also inclusion criteria for many systematic reviews of therapeutic interventions. However, the view that randomized trials provide better evidence has been challenged by philosophers of science. In addition, empirical evidence for average differences between randomized trials and observational studies (which we would expect if one method were superior) has proven difficult to find. This chapter reviews the controversy surrounding the relative merits of randomized trials and observational studies. It is concluded that while (well-conducted) observational can often provide the same level of evidential support as randomized trials, merits of (well-conducted) randomized trials warrant claims about their superiority, especially where results from the two methods are contradictory.

Place, publisher, year, edition, pages
Springer Nature , 2025. p. 1125-1138
Keywords [en]
Coronary Heart Disease, External Validity, Neuraminidase Inhibitor, Observational Study, Performance Bias
National Category
Health Care Service and Management, Health Policy and Services and Health Economy Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:kth:diva-384971DOI: 10.1007/978-94-024-2252-8_45Scopus ID: 2-s2.0-105024038364OAI: oai:DiVA.org:kth-384971DiVA, id: diva2:2085850
Note

Part of ISBN 9789402422528, 9789402422511

QC 20260710

Available from: 2026-07-10 Created: 2026-07-10 Last updated: 2026-07-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Mebius, Alexander

Search in DiVA

By author/editor
Mebius, Alexander
By organisation
Philosophy
Health Care Service and Management, Health Policy and Services and Health EconomyCardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 7 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf